21-33027194-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_005806.4(OLIG2):āc.332T>Gā(p.Leu111Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000745 in 1,610,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 33)
Exomes š: 0.0000062 ( 0 hom. )
Consequence
OLIG2
NM_005806.4 missense
NM_005806.4 missense
Scores
9
3
7
Clinical Significance
Conservation
PhyloP100: 6.12
Genes affected
OLIG2 (HGNC:9398): (oligodendrocyte transcription factor 2) This gene encodes a basic helix-loop-helix transcription factor which is expressed in oligodendroglial tumors of the brain. The protein is an essential regulator of ventral neuroectodermal progenitor cell fate. The gene is involved in a chromosomal translocation t(14;21)(q11.2;q22) associated with T-cell acute lymphoblastic leukemia. Its chromosomal location is within a region of chromosome 21 which has been suggested to play a role in learning deficits associated with Down syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.871
BS2
High AC in GnomAdExome4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OLIG2 | NM_005806.4 | c.332T>G | p.Leu111Arg | missense_variant | 2/2 | ENST00000382357.4 | NP_005797.1 | |
OLIG2 | XM_005260908.2 | c.332T>G | p.Leu111Arg | missense_variant | 2/2 | XP_005260965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OLIG2 | ENST00000382357.4 | c.332T>G | p.Leu111Arg | missense_variant | 2/2 | 1 | NM_005806.4 | ENSP00000371794 | P1 | |
ENST00000454622.2 | n.201+43710A>C | intron_variant, non_coding_transcript_variant | 2 | |||||||
OLIG2 | ENST00000333337.3 | c.332T>G | p.Leu111Arg | missense_variant | 1/1 | ENSP00000331040 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151760Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
151760
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000327 AC: 8AN: 244290Hom.: 0 AF XY: 0.0000377 AC XY: 5AN XY: 132542
GnomAD3 exomes
AF:
AC:
8
AN:
244290
Hom.:
AF XY:
AC XY:
5
AN XY:
132542
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459018Hom.: 0 Cov.: 35 AF XY: 0.00000689 AC XY: 5AN XY: 725592
GnomAD4 exome
AF:
AC:
9
AN:
1459018
Hom.:
Cov.:
35
AF XY:
AC XY:
5
AN XY:
725592
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151760Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74094
GnomAD4 genome
AF:
AC:
3
AN:
151760
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74094
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 30, 2023 | The c.332T>G (p.L111R) alteration is located in exon 2 (coding exon 1) of the OLIG2 gene. This alteration results from a T to G substitution at nucleotide position 332, causing the leucine (L) at amino acid position 111 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MutPred
Loss of stability (P = 0.0257);Loss of stability (P = 0.0257);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at